학술논문
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial
Document Type
Article
Author
Marzinke, M.A.; Richardson, P.A.; Sullivan, P.; Eshleman, S.H.; Hanscom, B.; Wang, Z.; Donnell, D.; Safren, S.A.; Psaros, C.; Jennings, A.; Feliciano, K.G.; Sanchez, N.; Lucas, J.; McCauley, M.; Jalil, E.; Coutinho, C.; Grinsztejn, B.; Cardozo, N.; Maia, B.; Khan, T.; Singh, Y.; Middelkoop, K.; Franks, J.; Valencia, J.; Rooney, J.F.; Rinehart, A.R.; Ford, S.; Adeyeye, A.; Cohen, M.S.; Landovitz, R.J.; Chariyalertsak, S.; Ungsedhapand, C.; Phanuphak, N.; Ha, T.V.; Figueroa, M.I.; Losso, M.H.; Kallas, E.G.; Valdez Madruga, J.; Riegel Santos, B.; Boyer, J.C.H.; Aguirre, M.E.M.; Gallardo-Cartagena, J.A.; Ramirez, Y.P.; Goepfert, P.; Hosek, S.; Liu, A.; Justman, J.; Hurt, C.; Reirden, D.; Fichtenbaum, C.; Hall, C.; Mayer, K.; Magnus, M.; van Dam, C.; Kelley, C.; Arduino, R.C.; Rompalo, A.; Swaminathan, S.; Abdalian, S.E.; Van Tieu, H.; Bazan, J.; Frank, I.; del Rio, C.; Gaur, A.; Landovitz, R.J.; Clark, J.; Novak, R.; Presti, R.; Gulick, R.T.
Source
In: The Lancet HIV . (The Lancet HIV, November 2023, 10(11):e703-e712)
Subject
Language
English
ISSN
23523018